Main content

Management

 

 

Kjetil Hestdal President and CEO

Kjetil Hestdal, MD, Ph.D., has served as President and CEO since January 2005. Dr. Hestdal held the position as Vice President Research and Development from January 1997 and was promoted to Chief Operating Officer in October 2004. Before joining Photocure, Dr Hestdal served as the Project Manager/Medical Expert at Sandoz (now Novartis) and as Senior Scientist at Rikshospitalet. Dr Hestdal holds a Ph.D. in immunology.

Dr Kjetil Hestdal holds directly or indirectly 66,373 shares in Photocure. In addition he holds 138,500 share options in the company.

 

Ambaw Bellete

Ambaw BelletePresident, Photocure Inc. and Head, US Cancer Commercial Operations

Ambaw Bellete joined the Company in 2012. He has over 22 years of experience in the biopharmaceutical and medical device industry. He has held senior executive positions across multiple therapeutic areas in business development, commercial operations, managed care, marketing and sales at companies such as Pharmacia and Sanofi. He was most recently President of Medical Compression Systems.

Ambaw Bellete holds no shares in Photocure. He holds 15,300 share options in the Company.

 

ERIK DAHL

Chief Financial Officer

Erik Dahl, joined Photocure in August 2012 as CFO. Most recently, he was CFO for GET AS, the second largest cable TV provider in Norway. He has more than 20 years of experience from senior level financial management roles, with responsibilities within corporate finance, legal and financial restructurings, M&A and capital market transactions. He has held various CFO roles in both public and private companies. Mr. Dahl has a Bachelor degree in finance and accounting from the Norwegian School of Economics.

Erik Dahls holds no shares in Photocure. He holds 30,000 share options in the Company.

 

Kathleen Deardorff

Kathleen DeardorffChief Operating Officer

Kathleen Deardorff, joined the Company in May 2011. She graduated from Purdue University School of Pharmacy, USA with her Pharm.D. Kathleen has held senior leadership positions in strategic marketing, operational marketing and business development, crossing multiple geographies at Bristol-Myers Squibb and GE Healthcare. Her most recent position was Head of Global Marketing at GEHC, encompassing strategy development and global execution for both marketed and pipeline products for medical diagnostics portfolio.

Kathleen Deardorff holds no shares in Photocure. She holds 95,295 share options in the Company.


 

Inger Ferner Heglund

 

Inger Ferner HeglundVice President Research and Development

Inger Ferner Heglund, joined Photocure in 2006 as Director, Business Relations and was appointed Vice President Research and Develeopment from January 2007. She has a degree in physiology from the University of Oslo and extensive experience within R&D. She has held various leadership positions in preclinical development and project management in GE Healthcare. Mrs Heglund comes from a position as Global Project Director in GE Healthcare.

Inger Ferner Heglund holds 8,200 shares in Photocure. She holds 88,680 share options in the company.

 

Grete Hogstad

Grete HogstadVice President Strategic Marketing

Grete Hogstad, joined Photocure in February 2005. She has a degree in pharmacy from the University of Oslo, as well as a business degree from the Norwegian School of Management. She has held various leading positions in Marketing and Sales in Alpharma and Novo Nordisk Pharma, and is a founding member of the Generics Association in Norway. Mrs. Hogstad comes from the position as Director Sales and Marketing for Norway, Sweden and Finland in Alpharma.

Grete Hogstad holds 10,500 shares in Photocure. She holds 69,200 share options in the company.

 

Espen Njåstein

 

Espen NjåsteinHead Nordic Cancer Commercial Operations

Espen Njåstein, joined Photocure in 2007 as Nordic Sales Manager. He was appointed Nordic Cancer Commercial Operations Director from July 2010 and Head Nordic Cancer Commercial Operations from January 2012. He has a degree in marketing from The Norwegian School of Marketing. Before joining Photocure, Espen Njåstein has held different positions within sales and marketing at Pfizer. He came from a position as Training and Development Manager in Pfizer.

Espen Njåstein holds no shares in Photocure. He holds 16,350 share options in the Company.

 

 

Gry Stensrud

 

Gry StensrudVice President Technical Development and Operations

Gry Stensrud, joined Photocure in May 2006 as Pharmaceutical Director. She was appointed Director Operations from April 2009 and Vice President Technical Development & Operations from October 2010. She holds a degree in Pharmacy and a Ph.D. in Pharmaceutical Technology from the University of Oslo. Before joining Photocure, Gry Stensrud has held different positions within R&D and QA at GE Healthcare. She came from a position as Manager Formulation Technology in GE Healthcare.

Gry Stensrud holds 6 shares in Photocure. She holds 68,350 share options in the company.

 

Espen Njåstein, Head Nordic Cancer Commercial Operations
Espen Njåstein, born 1967, joined Photocure in 2007 as Nordic Sales Manager. He was appointed Nordic Cancer Commercial Operations Director from July 2010 and Head Nordic Cancer Commercial Operations from January 2012. He has a degree in marketing from The Norwegian School of Marketing. Before joining Photocure, Espen Njåstein has held different positions within sales and marketing at Pfizer. He came from a position as Training and Development Manager in Pfizer.